The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Drugs for treatment of very high blood pressure during pregnancy
Open accessAbstract
BACKGROUND: Very high blood pressure during pregnancy poses a serious threat to women and their babies. The aim of antihypertensive therapy is to lower blood pressure quickly but safety, to avoid complications. Antihypertensive drugs lower blood pressure but their comparative effectiveness and safety, and impact on other substantive outcomes is uncertain. OBJECTIVES: To compare different antihypertensive drugs for very high blood pressure during pregnancy. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group Trials Register (9 January 2013). SELECTION CRITERIA: Studies were randomised trials. Participants were women with severe hypertension during pregnancy. Interventions were comparisons of one antihypertensive drug with another. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trials for inclusion and assessed trial quality. Two review authors extracted data and checked them for accuracy. MAIN RESULTS: Thirty-five trials (3573 women) with 15 comparisons were included. Women allocated calcium channel blockers were less likely to have persistent high blood pressure compared to those allocated hydralazine (six trials, 313 women; 8% versus 22%; risk ratio (RR) 0.37, 95% confidence interval (CI) 0.21 to 0.66). Ketanserin was associated with more persistent high blood pressure than hydralazine (three trials, 180 women; 27% versus 6%; RR 4.79, 95% CI 1.95 to 11.73), but fewer side-effects (three trials, 120 women; RR 0.32, 95% CI 0.19 to 0.53) and a lower risk of HELLP (haemolysis, elevated liver enzymes and lowered platelets) syndrome (one trial, 44 women; RR 0.20, 95% CI 0.05 to 0.81).Labetalol was associated with a lower risk of hypotension compared to diazoxide (one trial 90 women; RR 0.06, 95% CI 0.00 to 0.99) and a lower risk of caesarean section (RR 0.43, 95% CI 0.18 to 1.02), although both were borderline for statistical significance.Both nimodipine and magnesium sulphate were associated with a high incidence of persistent high blood pressure, but this risk was lower for nimodipine compared to magnesium sulphate (one trial, 1650 women; 47% versus 65%; RR 0.84, 95% CI 0.76 to 0.93). Nimodipine was associated with a lower risk of respiratory difficulties (RR 0.28, 95% CI 0.08 to 0.99), fewer side-effects (RR 0.68, 95% CI 0.55 to 0.85) and less postpartum haemorrhage (RR 0.41, 95% CI 0.18 to 0.92) than magnesium sulphate. Stillbirths and neonatal deaths were not reported.There are insufficient data for reliable conclusions about the comparative effects of any other drugs. AUTHORS' CONCLUSIONS: Until better evidence is available the choice of antihypertensive should depend on the clinician's experience and familiarity with a particular drug; on what is known about adverse effects; and on women's preferences. Exceptions are nimodipine, magnesium sulphate (although this is indicated for women who require an anticonvulsant for prevention or treatment of eclampsia), diazoxide and ketanserin, which are probably best avoided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Corticosteroids for HELLP syndrome in pregnancy
Matchaba, P. T., & Moodley, J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002076.pub2 · Cited by 100
RetractedPharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008
(2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02847.x · Cited by 2,994
Pre-eclampsia: more than pregnancy-induced hypertension
Roberts, J. M., & Redman, C. W. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)90889-o · Cited by 1,246
The Two Stage Model of Preeclampsia: Variations on the Theme
Roberts, J. M., & Hubel, C. A. (2009) · Placenta · doi:10.1016/j.placenta.2008.11.009 · Cited by 922
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
Abalos, E., Duley, L., & Steyn, D. W. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002252.pub3 · Cited by 705
Self-citationMagnesium sulphate and other anticonvulsants for women with pre-eclampsia
Duley, L., Gülmezoglu, A. M., Henderson-Smart, D. J., & Chou, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000025.pub2 · Cited by 586
Self-citationRETIRED: Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy
Magee, L. A., Helewa, M., Rey, E., Cardew, S., Côté, A.-M., Douglas, M. J., Firoz, T., Gibson, P. S., Gruslin A., A., Lange, I., et al. (2008) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32776-1 · Cited by 578
Saving Mothers’ Lives. Reviewing maternal deaths to make motherhood safer: 2006-2008: Correspondence
Wilkinson, H., & Advisers, O. B. O. T. T. A. M. (2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.03097.x · Cited by 512
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis
Magee, L. A., Cham, C., Waterman, E. J., Ohlsson, A., & von Dadelszen, P. (2003) · BMJ · doi:10.1136/bmj.327.7421.955 · Cited by 442
Clinical physiology in obstetrics
Chamberlain, G. V. P., & Hytten, F. E. (1998) · Medical Entomology and Zoology · Cited by 326
Guidelines for the management of hypertensive disorders of pregnancy 2008
LOWE, S. A., BROWN, M. A., DEKKER, G. A., GATT, S., McLINTOCK, C. K., McMAHON, L. P., MANGOS, G., MOORE, M. P., MULLER, P., PAECH, M., et al. (2009) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2009.01003.x · Cited by 296
A Comparison of Magnesium Sulfate and Nimodipine for the Prevention of Eclampsia
Belfort, M. A., Anthony, J., Saade, G. R., & Allen, J. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021180 · Cited by 279
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
Abalos, E., Duley, L., Steyn, D. W., & Henderson-Smart, D. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002252.pub2 · Cited by 263
Self-citationGeographic variation in the incidence of hypertension in pregnancy
World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90782-x · Cited by 216
Geographic variation in incidence of hypertension in pregnancy
Golding, J., & MacGillivray, I. (1988) · Bristol Research (University of Bristol) · Cited by 213
Lindheimer, M. D., Taler, S. J., & Cunningham, F. G. (2010) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2010.03.002 · Cited by 196
Duley, L., Meher, S., & Abalos, E. (2006) · BMJ · doi:10.1136/bmj.332.7539.463 · Cited by 185
Self-citationDrugs for treatment of very high blood pressure during pregnancy
Duley, L., Henderson-Smart, D. J., & Meher, S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001449.pub2 · Cited by 185
Self-citationCorticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy
Woudstra, D. M., Chandra, S., Hofmeyr, G. J., & Dowswell, T. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008148.pub2 · Cited by 180
Lindheimer, M. D., Taler, S. J., & Cunningham, F. G. (2008) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2008.10.001 · Cited by 169
Mabie, W., Gonzales, A. R., Sibai, B. M., & Amon, E. (1988) · Obstetric Anesthesia Digest · doi:10.1097/00132582-198804000-00039 · Cited by 168
Magnesium sulphate versus lytic cocktail for eclampsia
Duley, L., Gülmezoglu, A. M., & Chou, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002960.pub2 · Cited by 167
Self-citationNifedipine in the treatment of severe preeclampsia.
Fenakel, K., Fenakel, G., Appelman, Z., Lurie, S. B., Katz, Z., & Shoham, Z. (1991) · PubMed · Cited by 163
Samangaya, R. A., Mires, G., Shennan, A., Skillern, L., Howe, D., McLeod, A., & Baker, P. N. (2009) · Hypertension in Pregnancy · doi:10.3109/10641950802601278 · Cited by 159
Vermillion, S. T., Scardo, J. A., Newman, R., & Chauhan, S. P. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70314-5 · Cited by 150
Tomassoni, D., Lanari, A., Silvestrelli, G., et al. (2008) · Clinical and Experimental Hypertension · doi:10.1080/10641960802580232 · Cited by 148
Management of Hypertensive Disorders in Pregnancy
Moussa, H. N., Arian, S. E., & Sibai, B. M. (2014) · Women s Health · doi:10.2217/whe.14.32 · Cited by 128
Severe hypertension in pregnancy: Hydralazine or labetalol
Gracia, P. V., Lasso, M., Ruiz, E., Vega-Malek, J. C., de Mena, F. T., & López, J. C. (2006) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.02.015 · Cited by 123
Raheem, I. A., Saaid, R., Omar, S., et al. (2011) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.03151.x · Cited by 120
Mabie, W. C., González, A. R., Sibai, B., et al. (1988) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(88)90057-4 · Cited by 116
Chauleur, C., Molinari, N., Marès, P., Fabbro-Péray, P., Quéré, I., Lefrant, J., Haddad, B., Dauzat, M., & Gris, J. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0340 · Cited by 113
Interventionist versus expectant care for severe pre-eclampsia before term
Churchill, D. N., & Duley, L. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003106 · Cited by 85
Self-citationPlasma volume expansion for treatment of pre-eclampsia
Duley, L., Williams, J., & Henderson-Smart, D. J. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001805 · Cited by 74
Self-citationBrown, M. A., Buddle, M. L., Farrell, T., & Davis, G. K. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.126294 · Cited by 68
Intravenous Labetalol and Intravenous Dihydralazine in Severe Hypertension in Pregnancy
Garden, A., Davey, D. A., & Dommisse, J. (1982) · Clinical and Experimental Hypertension Part B Hypertension in Pregnancy · doi:10.3109/10641958209139860 · Cited by 65
Harper, A., & Murnaghan, G. A. (1991) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1991.tb10339.x · Cited by 60
Scardo, J. A., Vermillion, S. T., Newman, R., Chauhan, S. P., & Hogg, B. B. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70315-7 · Cited by 59
Hall, D. R., Odendaal, H. J., Steyn, D. W., & Smith, M. C. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb13337.x · Cited by 59
Effect of l-Arginine Therapy on the Glomerular Injury of Preeclampsia: A Randomized Controlled Trial
Hladunewich, M., Derby, G. C., Lafayette, R. A., Blouch, K. L., Druzin, M. L., & Myers, B. D. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000207637.01824.fe · Cited by 53
Maki, M., Kobayashi, T., Terao, T., Ikenoue, T., Satoh, K., Nakabayashi, M., Sagara, Y., Kajiwara, Y., & Urata, M. (2000) · PubMed · Cited by 50
Interventions for preventing pre-eclampsia and its consequences: generic protocol
Meher, S., Duley, L., & Authors, P. O. P.-E. C. R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005301 · Cited by 49
Self-citationNifedipine in acute hypertensive emergencies in pregnancy.
Sj, S., Moodley, J., & Becker, P. J. (1989) · PubMed · Cited by 49
Hennessy, A., Thornton, C. E., Makris, A., Ogle, R. F., Henderson-Smart, D. J., Gillin, A. G., & Child, A. (2007) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2007.00738.x · Cited by 48
Baggio, M. R. F., Martins, W. P., Calderon, A. C. S., Berezowski, A. T., Marcolin, A. C., Duarte, G. G., & Cavalli, R. D. C. (2010) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2010.10.006 · Cited by 47
Roes, E. M., Raijmakers, M. T. M., de Boo, T. M., Zusterzeel, P. L. M., Merkus, H. M. W. M., Peters, W. H. M., & Steegers, E. A. P. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.09.007 · Cited by 47
Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy.
Ashe, R. G., Moodley, J., Richards, M., & Rh, P. (1987) · PubMed · Cited by 46
Intravenous Labetalol and Intravenous Diazoxide in Severe Hypertension Complicating Pregnancy
Michael, C. A. (1986) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1986.tb01523.x · Cited by 43
Wacker, J., Werner, P., Walter‐Sack, I., & Bastert, G. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027825 · Cited by 43
Bolte, A. C., van Eyck, J., Kanhai, H. H. H., Bruinse, H. W., van Geijn, H. P., & Dekker, G. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70216-4 · Cited by 41
Unemori, E., Sibai, B. M., & Teichman, S. L. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.03838.x · Cited by 41
Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.
Walker, J. J., Greer, I. A., & Calder, A. A. (1983) · PubMed · Cited by 40
Kobayashi, T., Terao, T., Ikenoue, T., Sameshima, H., Nakabayashi, M., Kajiwara, Y., Maki, M., & BI 51.017 Study Group (2003) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2004-815632 · Cited by 33
Thaler, I. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00249-0 · Cited by 33
Ketanserin and hydralazine in hypertension in pregnancy--a randomised double-blind trial.
Rossouw, H. J., Howarth, G. R., & Odendaal, H. J. (1995) · PubMed · Cited by 31
Digoxin Immune Fab Treatment for Severe Preeclampsia
Adair, C. D., Buckalew, V. M., Graves, S. W., Lam, G. K., Johnson, D., Saade, G. R., Lewis, D. F., Robinson, C., Danoff, T. M., Chauhan, N., et al. (2010) · American Journal of Perinatology · doi:10.1055/s-0030-1249762 · Cited by 30
Interventions for treating pre-eclampsia and its consequences: generic protocol
Duley, L., Henderson-Smart, D. J., & Walker, G. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007756 · Cited by 30
Self-citationHyperuricaemia and preeclampsia: is there a pathogenic link?
Schackis, R. C. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.02.018 · Cited by 27
A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy
Moodley, J., & Gouws, E. (1992) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1992.tb13872.x · Cited by 26
Neonatal adaptation in hypertensive pregnancy — A study of labetalol vs hydralazine treatment
Hjertberg, R., Faxelius, G., & Lagercrantz, H. (1993) · Journal of Perinatal Medicine · doi:10.1515/jpme.1993.21.1.69 · Cited by 24
Duggan, P., McCowan, L. M. E., & Stewart, A. W. (1992) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1992.tb02846.x · Cited by 23
A Comparison of Magnesium Sulfate and Nimodipine for the Prevention of Eclampsia
Belfort, M. A., Anthony, J., Saade, G. R., et al. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000079642.69018.34 · Cited by 22
Hjertberg, R., Faxelius, G., & Belfrage, P. (1993) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349309021152 · Cited by 21
Martínez‐Abundis, E., González-Ortíz, M., Hernández-Salazar, F., & Huerta-J-Lucas, M. T. (2000) · Gynecologic and Obstetric Investigation · doi:10.1159/000010278 · Cited by 20
Phosphodiesterase Inhibitor Effect on Small Artery Function in Preeclampsia
Samangaya, R. A., Wareing, M., Skillern, L., & Baker, P. N. (2010) · Hypertension in Pregnancy · doi:10.3109/10641955.2010.484083 · Cited by 18
Effectiveness of Antihypertensive Drugs in the Treatment of Hypertension in Pregnancy
Voto, L. S., Quiroga, C., Lapidus, A. M., Catuzzi, P., Imaz, F. U., & Margulies, M. (1990) · Clinical and Experimental Hypertension Part B Hypertension in Pregnancy · doi:10.3109/10641959009012940 · Cited by 12
Begum, M. R., Quadir, E., Begum, A., Akhter, S., & Rahman, K. (2002) · PubMed · Cited by 9
[The effect of Nifedipine on postpartum blood loss in patients with pregnancy induced hypertension].
Yang, X., & Liu, Y. (2000) · PubMed · Cited by 7
Decano, M. B. (2000) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(00)82035-4 · Cited by 6
Redman, C. W. G. (2002) · Wiley eBooks · doi:10.1002/9780470752371.ch6 · Cited by 6
Research works printed but not linked: 95
- Hennessy, 2006, Parenteral intravenous optimal therapy trial - A RCT of hydralazine versus mini-bolus diazoxide for hypertensive crises in the obstetric setting [abstract], Hypertension in Pregnancy, 25, 22
- Martins-Costa, 1992, Randomized, controlled trial of hydralazine versus nifedpine in preeclamptic women with acute hypertension, Clinical and Experimental Hypertension, B11, 25
- Mesquita MR Attalah AN Camano L Bertini AM The use of hydralazine and nifedipine as treatment of hypertension emergency during pregnancy Proceedings of 2nd World Congress of Perinatal Medicine; 1993 September 19-24; Rome, Italy 1993 41 · doi:10.1016/0165-0378(93)90019-e
- Souza, 1994, Use of hydralazine and nifedipine in hypertensive emergency in pregnancy, Progresos de Obstetricia y Ginecologia, 37, 90
- de Souza Mesquita MR Atallah AN Bertini AM The use of hydralazine and nifedipine as treatment for hypertension emergency during pregnancy Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland 1994 163
- Moore, 1982, The treatment of hypertension in pregnancy, Current Medical Research and Opinion, 8, S39, 10.1185/03007998209110129 · doi:10.1185/03007998209110129
- Vizitiu, 2010, Urapidyl for hypertension control in severe pre-eclampsia: a comparative study with nicardipine, Critical Care, 14 Suppl 1, S48
- Schulz, 2001, Effect of urapidil in antihypertensive therapy of preeclampsia on newborns, Zentralblatt fur Gynakologie, 123, 529, 10.1055/s-2001-18226 · doi:10.1055/s-2001-18226
- Wacker, 1994, Treatment of patients with pre-eclampsia with urapidil, International Journal of Gynecology & Obstetrics, 46, 121
- Wacker J Christ M Muller J Grischke EM Bastert G Treatment of patients with pre-eclampsia with urapidil Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland 1994 186
- Wacker J Piel P Bastert G The treatment of pre-eclampsia with urapidil Proceedings of 10th World Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA 1996 185
- Wacker, 2006, Antihypertensive therapy in patients with pre-eclampsia: a prospective randomised multicentre study comparing dihydralazine with urapidil, European Journal of Obstetrics & Gynecology and Reproductive Biology, 127, 160, 10.1016/j.ejogrb.2005.09.013 · doi:10.1016/j.ejogrb.2005.09.013
- Aali, 2002, Nifedipine or hydralazine as a first-line agent to control hypertension in severe pre-eclampsia, Acta Obstetricia et Gynecologica Scandinavica, 81, 25, 10.1034/j.1600-0412.2002.810105.x · doi:10.1034/j.1600-0412.2002.810105.x
- Rezaei, 2011, Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy, Acta Medica Iranica, 49, 701
- Rodriguez, 1989, Severe preeclamsia. Nifedipine versus chlorpromazine in the management of the acute hypertensive state, Revista Medica Instituto Mexicano del Seguro Social, 27, 359
- Walss Rodriguez, 1993, Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive drugs, Ginecologia y Obstetricia de Mexico, 61, 76
- Vargas, 1998, Efficacy of isosorbide in aerosol form in the management of hypertensive crisis in severe preeclampsia, Ginecologia y Obstetricia de Mexico, 66, 316
- Bolte, 1995, Comparison of the effectivity and safety of ketanserin versus dihydralazine in the treatment of severe early onset pre-eclampsia, American Journal of Obstetrics and Gynecology, 172, 384, 10.1016/0002-9378(95)91140-5 · doi:10.1016/0002-9378(95)91140-5
- Bolte AC Dekker GA van Eyck J Bruinse HW Kanhai HH de Vries A Ketanserin versus dihydralazine in the treatment of early onset pre-eclampsia Proceedings of 10th International Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA 1996 148
- Bolte AC Dekker GA van Eyck J Bruinse HW Kanhai HH de Vries A Comparison of the effectivity and safety of ketanserin versus dihydralazine in the treatment of severe early onset preeclampsia Proceedings of the International Society for the Study of Hypertension in Pregnancy, European Branch; 1995 July 20-22; Leuven Belgium 1995 18
- Bolte AC Dekker GA van Eyck J Strack van Schijndel RJM de Vries A van Geijn HP Comparison of the effectivity and safety of ketanserin vs dihydralazine in the treatment of severe pre-eclampsia Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia 1994 42
- Bolte, 1998, The haemodynamic effects of ketanserin versus dihydralazine in severe early onset hypertension in pregnancy, British Journal of Obstetrics and Gynaecology, 105, 723, 10.1111/j.1471-0528.1998.tb10202.x · doi:10.1111/j.1471-0528.1998.tb10202.x
- Bolte, 2001, Use of ketanserin in hypertensive disorders of pregnancy [abstract], American Journal of Obstetrics and Gynecology, 185, S171, 10.1016/S0002-9378(01)80357-4 · doi:10.1016/s0002-9378(01)80357-4
- Bolte, 2002, Ketanserin, a serotonin2 receptor blocker, for hypertension in pregnancy, Hypertension in Pregnancy, 21, 9
- Bolte, 2003, Ketanserin for hypertension in pregnancy, Australian and New Zealand Journal of Obstetrics and Gynaecology, 43, 179
- Belfort, 1998, Interim report of the nimodipine vs. magnesium sulfate for seizure prophylaxis in severe preeclampsia study: an international, randomized controlled trial, American Journal of Obstetrics and Gynecology, 178, S7
- Belfort, 1998, Change in estimated cerebral perfusion pressure following nimodipine or magnesium sulfate in patients with severe preeclampsia, American Journal of Obstetrics and Gynecology, 178, S114
- Belfort, 1999, Change in estimated cerebral perfusion pressure after treatment with nimodipine or magnesium sulfate in patients with preeclampsia, American Journal of Obstetrics and Gynecology, 181, 402, 10.1016/S0002-9378(99)70569-7 · doi:10.1016/s0002-9378(99)70569-7
- Moodley J The use of nifedipine in acute hypertensive emergencies of pregnancy Proceedings of 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Canada 1988 141
- Howarth, 1997, A randomized controlled pilot study comparing urapidil to dihydralazine in the management of severe hypertension in pregnancy, Hypertension in Pregnancy, 16, 213, 10.3109/10641959709031638 · doi:10.3109/10641959709031638
- Pattinson RC Seris A Venter CP Howarth G Urapidil versus dihydralazine for control of severe hypertension in pregnancy: a pilot study Proceedings of the 12th Conference on Priorities in Perinatal Care; 1993; South Africa 1993 140 3
- Maharaj, 1997, A comparative study of intravenous isradipine and dihydralazine in the treatment of severe hypertension of pregnancy in black patients, Hypertension in Pregnancy, 16, 1, 10.3109/10641959709069085 · doi:10.3109/10641959709069085
- Maharaj B Moodley J Khedun SM Rapiti N van der Byl K Intravenous isradipine in the management of severe hypertension in pregnancy Proceedings of 10th International Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA 1996 131
- Maharaj B Moodley J Khedun SM Rapiti N van der Byl K Intravenous isradipine in the management of severe hypertension in pregnancy Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia 1994 158
- Steyn DW Odendaal HJ Dihydralazine or ketanserin for severe hypertension in pregnancy? Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia 1994 152
- Steyn, 1997, Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results, European Journal of Obstetrics & Gynecology and Reproductive Biology, 75, 155, 10.1016/S0301-2115(97)00123-1 · doi:10.1016/s0301-2115(97)00123-1
- Hall, 2000, Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial, Hypertension in Pregnancy, 19, 12
- Hall DR Odendaal HJ Steyn DW Smith M Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial Women's Health - into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3-6; Cape Town South Africa RCOG 1999 49
- Elatrous, 2002, Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol, Intensive Care Medicine, 28, 1281, 10.1007/s00134-002-1406-3 · doi:10.1007/s00134-002-1406-3
- Belfort M Taskin O Buhur A Saade G Yalcinoglu A Intravenous nimodipine in the management of severe preeclampsia: a double blind randomised controlled clinical trial Proceedings of 10th International Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA 1996 124
- Mabie WC Gonzalez-Ruiz A Amon E Sibai BM A comparative trial of labetolol and hydralazine for acute management of severe hypertension complicating pregnancy Proceedings of 5th International Congress, International Society for the Study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, UK 1987 91
- Adair, 2009, The hemodynamic effects of intravenous digoxin-binding fab immunoglobulin in severe preeclampsia: a double-blind, randomized, clinical trial, Journal of Perinatology, 29, 284, 10.1038/jp.2008.224 · doi:10.1038/jp.2008.224
- Adair, 2010, Digoxin Immune Fab treatment for severe preeclampsia; relationship between response and baseline endogenous digitalis-like factor, Pregnancy Hypertension, 1 Suppl 1, S21, 10.1016/S2210-7789(10)60093-1 · doi:10.1016/s2210-7789(10)60093-1
- Voto L Lapidus A Neira J Margulies M Atenolol versus alpha methyl dopa in the treatment of hypertension in pregnancy Proceedings of the 5th International Congress, International Society for the Study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, UK, 1986 1986 138
- Aslam, 2007, Pregnancy induced hypertension; anti-hypertensive therapy in a study using single drug versus multiple drugs, Professional Medical Journal, 14, 30, 10.29309/TPMJ/2007.14.01.3619 · doi:10.29309/tpmj/2007.14.01.3619
- Buddle ML Brown MA Farrell T Rapid treatment of severe hypertension in pregnancy 37th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology; 2001 September 5-7; Darwin, Australia 2001 118 · doi:10.1046/j.1440-1797.2002.00007-1-118.x
- Kahhale, 1985, Comparative study of chronic hypertensive pregnant women treated and non-treated with pindolol, Ginecologia e Obstetricia Brasileiras, 8, 85
- Bruno, 1988, Nifedipine versus hydralazine: randomized, placebo-controlled and double blind trial in severe hypertension complicating pregnancy, Revista do Hospital de Clinicas de Porto Alegre, 8, 75
- Atallah, 1990, A randomized controlled study of hydralazine and nifedipine in hypertensive crisis during pregnancy, Revista Brasileira de Ginecologia y Obstetricia, 12, 10
- Devi, 2012, Intravenous labetalol versus oral nifedipine in the treatment of severe hypertension in pregnancy, Kuwait Medical Journal, 44, 287
- Toppozada, 1989, Management of severe pre-eclampsia with prostaglandin A1: a useful therapeutic approach, Journal of Obstetrics and Gynaecology, 9, 184, 10.3109/01443618909151031 · doi:10.3109/01443618909151031
- Toppozada, 1992, Improving placental blood flow in pre-eclampsia with prostaglandin A1, Acta Obstetricia et Gynecologica Scandinavica, 71, 22, 10.3109/00016349209007942 · doi:10.3109/00016349209007942
- Esmaoglu, 2009, Comparison between dexmedetomidine and midazolam for sedation of eclampsia patients in the intensive care unit, Journal of Critical Care, 24, 551, 10.1016/j.jcrc.2009.02.001 · doi:10.1016/j.jcrc.2009.02.001
- Kwawukume, 1995, Oral nifedipine therapy in the management of severe preeclampsia, International Journal of Gynecology & Obstetrics, 49, 265, 10.1016/0020-7292(95)02372-J · doi:10.1016/0020-7292(95)02372-j
- Graves, 2012, Deep trial secondary analysis: Digoxin immune fab fragment treatment has additional benefits in endogenous digitalis-like factor positive preeclamptic women, Pregnancy Hypertension, 2, 287, 10.1016/j.preghy.2012.04.198 · doi:10.1016/j.preghy.2012.04.198
- Hopate, 2008, In-vivo reversal of functional sodium pump inhibition with Digibind treatment, Hypertension in Pregnancy, 27, 460
- Daftary, 1963, A controlled clinical trial of guanethidine in toxemia of pregnancy, Indian Journal of Medical Sciences, 17, 812
- Samal, 2001, Management of eclampsia with magnesium sulphate and nifedipine, Journal of Obstetrics and Gynecology of India, 51, 71
- Ghahiri, 1994, The effect of nifedipin on the BP of the patients with severe preeclampsia, International Journal of Gynecology & Obstetrics, 46, 121
- Paternoster, 2004, Efficacy of AT in pre-eclampsia: a case control prospective trial, Thrombosis and Haemostasis, 91, 283, 10.1160/TH03-06-0388 · doi:10.1160/th03-06-0388
- Fletcher, 1999, An open trial comparing isradipine with hydralazine and methyl dopa in the treatment of patients with severe pre-eclampsia, Journal of Obstetrics and Gynaecology, 19, 235, 10.1080/01443619964977 · doi:10.1080/01443619964977
- Fletcher, 1996, An open trial comparing usual care (hydralazine) with injectable isradipine in severe pre-eclampsia [abstract], West Indian Medical Journal, 45, 27
- Kanayama, 1999, A new treatment of severe pre-eclampsia by long term epidural anaesthesia, Journal of Human Hypertension, 13, 167, 10.1038/sj.jhh.1000783 · doi:10.1038/sj.jhh.1000783
- Seki, 2002, Long-term treatment with nicardipine for severe pre-eclampsia, International Journal of Gynecology & Obstetrics, 76, 135, 10.1016/S0020-7292(01)00569-0 · doi:10.1016/s0020-7292(01)00569-0
- Lam, 2008, Antepartum administration of a digoxin immune fab (Digibind) improves renal function in patients with severe preeclampsia, Hypertension in Pregnancy, 27, 422
- Jegasothy, 1996, Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice, Journal of Obstetrics and Gynaecology Research, 22, 21, 10.1111/j.1447-0756.1996.tb00930.x · doi:10.1111/j.1447-0756.1996.tb00930.x
- Manzur-Verastegui, 2008, Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial, Clinical and Experimental Pharmacology and Physiology, 35, 580, 10.1111/j.1440-1681.2007.04838.x · doi:10.1111/j.1440-1681.2007.04838.x
- Pardo-Morales, 2004, New therapeutics alternative in severe preeclampsia, Cirugia y Cirujanos, 72, 203
- Roes, 2002, Oral n-acetylcysteine supplementation does not prolong pregnancy in women with severe preeclampsia: a randomised, placebo-controlled trial [abstract], Hypertension in Pregnancy, 21, 47
- Pogue, 2006, Removal of agonistic autoantibodies against the angiotensin AT receptor in patients with preeclampsia [abstract], Journal of the American Society of Nephrology, 17, 658A
- Ratnam, 1971, A comparison of hypotensive drugs in patients with hypertensive disorders in late pregnancy, Australian and New Zealand Journal of Obstetrics and Gynaecology, 11, 78, 10.1111/j.1479-828X.1971.tb00458.x · doi:10.1111/j.1479-828x.1971.tb00458.x
- Smith, 2005, Oral labetalol given to treated non hypertensive patients with preeclampsia is no more likely to cause hypotension than magnesium sulfate [abstract], American Journal of Obstetrics and Gynecology, 193, S78, 10.1016/j.ajog.2005.10.282 · doi:10.1016/j.ajog.2005.10.282
- Sankar, 1984, Low-dose diazoxide in the emergency management of severe hypertension in pregnancy, South African Medical Journal, 65, 279
- Bhorat, 1993, Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine, American Journal of Obstetrics and Gynecology, 168, 1292, 10.1016/0002-9378(93)90383-T · doi:10.1016/0002-9378(93)90383-t
- Bhorat IE Naidoo DP Rout CC Moodley J Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 march 15-18; Sydney, Australia 1994 162
- Schie, 2002, The optimal dosage of ketanserin for pateints with severe hypertension in pregnancy, European Journal Obstetrics & Gynecology and Reproductive Biology, 102, 161, 10.1016/S0301-2115(01)00611-X · DOI
- Cararach V Torres Pons PJ Roca M Codina C Cobo E Gonzalez-Merlo J Treatment of severe hypertension in pregnancy. Double blind controlled trial a treatment pattern (TP) with hydralazine + methyldopa a single TP with labetolol Proceedings of 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Canada 1988 101
- Steyn DW Hall DR Odendaal H The optimal dosage of nifedipine in patients with early onset severe pre-eclampsia - a randomised controlled trial 22nd Conference on Priorities in Perinatal Care in South Africa; 2003 March 11-14; Free State, South Africa 2003
- Hjertberg R Faxelius G Lagercrantz H Neonatal adaptation in hypertensive pregnancy - a study of labetalol vs hydralazine treatment Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland 1994 18
- Scardo, 1999, Randomized double blinded hemodynamic study of oral nifedipine and IV labetolol in hypertensive urgencies of pregnancy, American Journal of Obstetrics and Gynecology, 180, S18
- Vermillion, 1999, A prospective randomized double blind trial of oral nifedipine and intravenous labetolol in hypertensive emergencies, American Journal of Obstetrics and Gynecology, 180, S14
- Reyna-Villasmil, 2001, Effect of transdermal nitroglycerin on umbilical artery blood flow in preeclampsia [abstract], Journal of Perinatal Medicine, 29 Suppl 1, 486
- Waheed, 2005, Comparison of intravenous hydralazine-bolus dose versus continuous infusion drip in eclampsia, Annals of King Edward Medical College, 11, 521
- Warren, 2004, First interim report on the labetalol versus magnesium sulfate for the prevention of eclampsia trial (LAMPET) [abstract], Hypertension in Pregnancy, 23, 9
- Mesquita, 1995, The use of hydralazine and nifedipine in hypertensive emergencies in pregnancy, Revista Brasileira de Ginecologia e Obstetricia, 17, 103
- Clarke M Oxman AD Cochrane Reviewers’ Handbook 4.1.5 [updated April 2002] In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated quarterly
- Hennessy, 2007, A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial, Australian and New Zealand Journal of Obstetrics and Gynaecology, 47, 279, 10.1111/j.1479-828X.2007.00738.x · DOI
- The Cochrane Collaboration Review Manager (RevMan) 2000
- The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011
- Duley L IV labetalol vs iv diazoxide in severe pre-eclampsia In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995
- Duley L Labetalol vs hydralazine in severe pregnancy-induced hypertension In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995
- Duley L Nifedipine vs hydralazine in severe pregnancy-induced hypertension In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995
- Duley L Prostacyclin vs dihydralazine in severe hypertension In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995
- Duley, 1999, Drugs for rapid treatment of very high blood pressure during pregnancy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001449 · doi:10.1002/14651858.cd001449
- Duley, 2002, Drugs for rapid treatment of very high blood pressure during pregnancy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001449 · doi:10.1002/14651858.cd001449
Cited by
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
The Global Impact of Pre-eclampsia and Eclampsia
Duley, L. (2009) · Seminars in Perinatology · doi:10.1053/j.semperi.2009.02.010 · Cited by 2,866
Self-citationWilliams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
Metadata
- Authors
- Duley, L., Meher, S., & Jones, L.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-07-31
- Volume
- 2013
- Issue
- 7
- Pages
- CD001449-CD001449
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1693011515
- Cited by
- 423
- References
- 72
- FWCI
- 37.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.